Malignant Endocrine Neoplasm — Trials

Malignant Endocrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,801 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 576
Recruiting: 291
Ph III recruiting: 33
Growth YoY: +2.2%
Industry share: 34%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (238)

clinicaltrialsPublishedShowing 251–280 of 280 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00284154	Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer	completed	Phase 2	51	SCRI Development Innovations, LLCOTHER	1	Mar 13, 2013	clinicaltrials
NCT00028028	CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer	completed	Phase 2	80	National Cancer Institute (NCI)NIH	1	Feb 28, 2013	clinicaltrials